Dr. Josh Rising is Pew’s director of health care programs, overseeing the medical device initiative and the improving end-of-life care project.
Before joining Pew, Rising helped establish the Office of Policy in the Food and Drug Administration’s Center for Tobacco Products. He also served as health policy analyst for the Connecticut Legislature, focusing on issues of health care access, Medicaid policy, health information technology, and health care quality. He also was legislative affairs director for the American Medical Student Association.
Rising received his medical degree and his master’s degree in public health from Boston University, completed his pediatric residency at the University of California, San Francisco, and trained for a year as a Robert Wood Johnson clinical scholar at Yale University.
Recent WorkView All
Although the United States has invested tens of billions of dollars to encourage providers to adopt electronic health records (EHRs), many clinicians have found that these systems have poor “usability.” EHRs can put patients at risk of medical error, do little to enhance clinical care, and increase the time clinicians spend documenting patient care. Read More
The current system for evaluating implanted medical devices provides inadequate information on theperformance of the products used. This hinders prompt identification of failures and often requires lengthy andcostly studies to investigate technologies both before and after approval. Better integration of medical records,registries, and other data sources would ensure that the Food and Drug... Read More
The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have joined forces to push to include the codes—known as unique device identifiers (UDIs)— in Medicare claims. Read More